Trial Outcomes & Findings for Clinical Evaluation of Approved and Investigational Contact Lenses (NCT NCT02669095)

NCT ID: NCT02669095

Last Updated: 2017-06-09

Results Overview

Lens fit was assessed and recorded for each subject and eye at post lens fitting, 1-, 2-, 3- and 4- week follow-up evaluations. Lens fit was a binary response acceptable and unacceptable lens fit. The proportion of eyes with acceptable lens fitting at post lens fit and across all four follow-ups was combined and reported.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

150 participants

Primary outcome timeframe

Up to 4 Week Follow-up

Results posted on

2017-06-09

Participant Flow

A total of 150 subjects were enrolled in this study. All subjects enrolled into the study were dispensed a study lens. Of the dispensed subjects 146 completed the study and 4 subjects were discontinued.

Participant milestones

Participant milestones
Measure
Senofilcon C
Subjects that were randomized to receive the senofilcon C lens throughout the entire duration of the study.
Comfilcon A
Subjects that were randomized to receive the comfilcon A lens throughout the entire duration of the study.
Overall Study
STARTED
75
75
Overall Study
COMPLETED
74
72
Overall Study
NOT COMPLETED
1
3

Reasons for withdrawal

Reasons for withdrawal
Measure
Senofilcon C
Subjects that were randomized to receive the senofilcon C lens throughout the entire duration of the study.
Comfilcon A
Subjects that were randomized to receive the comfilcon A lens throughout the entire duration of the study.
Overall Study
Adverse Event
1
0
Overall Study
Unsatisfactory Lens Fitting
0
1
Overall Study
Torn Lens
0
1
Overall Study
Visit 5 assessments not completed
0
1

Baseline Characteristics

Clinical Evaluation of Approved and Investigational Contact Lenses

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Senofilcon C
n=75 Participants
Subjects that were randomized to receive the senofilcon C lens throughout the entire duration of the study.
Comfilcon A
n=75 Participants
Subjects that were randomized to receive the comfilcon A lens throughout the entire duration of the study.
Total
n=150 Participants
Total of all reporting groups
Age, Continuous
28.2 Years
STANDARD_DEVIATION 6.05 • n=5 Participants
30.2 Years
STANDARD_DEVIATION 5.62 • n=7 Participants
29.2 Years
STANDARD_DEVIATION 5.91 • n=5 Participants
Sex: Female, Male
Female
55 Participants
n=5 Participants
61 Participants
n=7 Participants
116 Participants
n=5 Participants
Sex: Female, Male
Male
20 Participants
n=5 Participants
14 Participants
n=7 Participants
34 Participants
n=5 Participants
Race/Ethnicity, Customized
Asian
2 Participants
n=5 Participants
2 Participants
n=7 Participants
4 Participants
n=5 Participants
Race/Ethnicity, Customized
Black or African American
12 Participants
n=5 Participants
7 Participants
n=7 Participants
19 Participants
n=5 Participants
Race/Ethnicity, Customized
White
61 Participants
n=5 Participants
65 Participants
n=7 Participants
126 Participants
n=5 Participants
Race/Ethnicity, Customized
Other
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
Region of Enrollment
North America
75 Participants
n=5 Participants
75 Participants
n=7 Participants
150 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Up to 4 Week Follow-up

Population: Subjects that completed all study visits without a major protocol deviation.

Lens fit was assessed and recorded for each subject and eye at post lens fitting, 1-, 2-, 3- and 4- week follow-up evaluations. Lens fit was a binary response acceptable and unacceptable lens fit. The proportion of eyes with acceptable lens fitting at post lens fit and across all four follow-ups was combined and reported.

Outcome measures

Outcome measures
Measure
Senofilcon C
n=740 Subject Eyes
Subjects that were randomized to receive the senofilcon C lens throughout the entire duration of the study.
Comfilcon A
n=720 Subject Eyes
Subjects that were randomized to receive the comfilcon A lens throughout the entire duration of the study.
Acceptable Lens Fitting
1 Proportion of eyes
0.99 Proportion of eyes

PRIMARY outcome

Timeframe: Up to 4 Week Follow-up

Population: Subjects that completed all study visits without a major protocol deviation.

Clue comfort was assessed using the Contact Lens User Experience™ (CLUE) questionnaire. CLUE is a validated patient-reported outcomes (PRO) questionnaire to assess patient-experience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0-120. CLUE Comfort was assessed at 1-, 2-, 3 and 4- week Follow-up evaluations. The average CLUE comfort score for each lens was reported for each visit.

Outcome measures

Outcome measures
Measure
Senofilcon C
n=74 Participants
Subjects that were randomized to receive the senofilcon C lens throughout the entire duration of the study.
Comfilcon A
n=72 Participants
Subjects that were randomized to receive the comfilcon A lens throughout the entire duration of the study.
Overall Comfort
1-Week Follow-up
71.75 Units on a scale
Standard Deviation 22.193
56.68 Units on a scale
Standard Deviation 27.747
Overall Comfort
2-Week Follow-up
70.58 Units on a scale
Standard Deviation 22.500
54.69 Units on a scale
Standard Deviation 30.268
Overall Comfort
3-Week Follow-up
68.75 Units on a scale
Standard Deviation 26.108
53.43 Units on a scale
Standard Deviation 29.912
Overall Comfort
4-Week Follow-up
68.25 Units on a scale
Standard Deviation 27.137
54.57 Units on a scale
Standard Deviation 30.522

Adverse Events

Senofilcon C

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Comfilcon A

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Kristy Canavan, O.D., FAAO Principal Research Optometrist

Johnson & Johnson Vision Care Inc.

Phone: 904 443-1474

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place

Restriction type: GT60